{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:45:22Z","timestamp":1790239522479,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40635-019-0255-0","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T16:03:46Z","timestamp":1557936226000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats"],"prefix":"10.1186","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3885-9569","authenticated-orcid":false,"given":"Alice","family":"Blet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Deniau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Geven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malha","family":"Sadoune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Robert","family":"Kounde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Polidano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pickkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane-Lise","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Mebazaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"key":"255_CR1","doi-asserted-by":"publisher","unstructured":"Angus DC, van der Poll T (2013) Severe sepsis and septic shock. N Engl J Med 369:840\u2013851 \n                    https:\/\/doi.org\/10.1056\/NEJMra1208623","DOI":"10.1056\/NEJMra1208623"},{"key":"255_CR2","doi-asserted-by":"publisher","unstructured":"Singer M, Deutschman CS, Seymour CW et al (2016) The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 315:801\u2013810 \n                    https:\/\/doi.org\/10.1001\/jama.2016.0287","DOI":"10.1001\/jama.2016.0287"},{"key":"255_CR3","doi-asserted-by":"publisher","unstructured":"Mebazaa A, Motiejunaite J, Gayat E et al (2018) Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry. Eur J Heart Fail 20:332\u2013341 \n                    https:\/\/doi.org\/10.1002\/ejhf.991","DOI":"10.1002\/ejhf.991"},{"key":"255_CR4","doi-asserted-by":"publisher","unstructured":"Kitamura K, Kangawa K, Kawamoto M et al (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553\u2013560 \n                    https:\/\/doi.org\/10.1006\/bbrc.1993.1451","DOI":"10.1006\/bbrc.1993.1451"},{"key":"255_CR5","first-page":"255","volume":"14","author":"WK Samson","year":"1999","unstructured":"Samson WK, Resch ZT, Murphy TC et al (1999) Adrenomedullin: is there physiological relevance in the pathology and pharmacology? News Physiol Sci Int J Physiol Prod Jointly Int Union Physiol Sci Am Physiol Soc 14:255\u2013259","journal-title":"News Physiol Sci Int J Physiol Prod Jointly Int Union Physiol Sci Am Physiol Soc"},{"key":"255_CR6","doi-asserted-by":"publisher","unstructured":"Hinson JP, Kapas S, Smith DM (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 21:138\u2013167 \n                    https:\/\/doi.org\/10.1210\/edrv.21.2.0396","DOI":"10.1210\/edrv.21.2.0396"},{"key":"255_CR7","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1001\/archsurg.133.12.1298","volume":"133","author":"P Wang","year":"1998","unstructured":"Wang P, Ba ZF, Cioffi WG et al (1998) The pivotal role of adrenomedullin in producing hyperdynamic circulation during the early stage of sepsis. Arch Surg Chic Ill 133:1298\u20131304","journal-title":"Arch Surg Chic Ill"},{"key":"255_CR8","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1016\/S0196-9781(01)00508-3","volume":"22","author":"MG Nicholls","year":"2001","unstructured":"Nicholls MG, Lainchbury JG, Lewis LK et al (2001) Bioactivity of adrenomedullin and proadrenomedullin N-terminal 20 peptide in man. Peptides 22:1745\u20131752","journal-title":"Peptides"},{"key":"255_CR9","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1161\/01.RES.0000036603.61868.F9","volume":"91","author":"S Hippenstiel","year":"2002","unstructured":"Hippenstiel S, Witzenrath M, Schmeck B et al (2002) Adrenomedullin reduces endothelial hyperpermeability. Circ Res 91:618\u2013625","journal-title":"Circ Res"},{"key":"255_CR10","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1160\/TH07-02-0128","volume":"98","author":"B Temmesfeld-Wollbr\u00fcck","year":"2007","unstructured":"Temmesfeld-Wollbr\u00fcck B, Hocke AC, Suttorp N, Hippenstiel S (2007) Adrenomedullin and endothelial barrier function. Thromb Haemost 98:944\u2013951","journal-title":"Thromb Haemost"},{"key":"255_CR11","doi-asserted-by":"publisher","unstructured":"Geven C, Bergmann A, Kox M, Pickkers P (2018) Vascular effects of adrenomedullin and the anti-adrenomedullin antibody Adrecizumab in sepsis. Shock 50(2):132-40. \n                    https:\/\/doi.org\/10.1097\/SHK.0000000000001103\n                    \n                  .","DOI":"10.1097\/SHK.0000000000001103"},{"key":"255_CR12","doi-asserted-by":"publisher","unstructured":"Kuwasako K, Kitamura K, Nagata S et al (2011) Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 32:1540\u20131550 \n                    https:\/\/doi.org\/10.1016\/j.peptides.2011.05.022","DOI":"10.1016\/j.peptides.2011.05.022"},{"key":"255_CR13","doi-asserted-by":"publisher","unstructured":"Marino R, Struck J, Maisel AS et al (2014) Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis. Crit Care Lond Engl 18:R34 \n                    https:\/\/doi.org\/10.1186\/cc13731","DOI":"10.1186\/cc13731"},{"key":"255_CR14","doi-asserted-by":"publisher","unstructured":"Rey C, Garc\u00eda-Hern\u00e1ndez I, Concha A et al (2013) Pro-adrenomedullin, pro-endothelin-1, procalcitonin, C-reactive protein and mortality risk in critically ill children: a prospective study. Crit Care Lond Engl 17:R240 \n                    https:\/\/doi.org\/10.1186\/cc13064","DOI":"10.1186\/cc13064"},{"key":"255_CR15","doi-asserted-by":"publisher","unstructured":"Caironi P, Latini R, Struck J et al (2017) Circulating biologically active adrenomedullin (bio-ADM) predicts hemodynamic support requirement and mortality during sepsis. Chest 152:312\u2013320 \n                    https:\/\/doi.org\/10.1016\/j.chest.2017.03.035","DOI":"10.1016\/j.chest.2017.03.035"},{"key":"255_CR16","doi-asserted-by":"publisher","unstructured":"Simon T-P, Martin L, Doemming S et al (2016) Plasma adrenomedullin in critically ill patients with sepsis after major surgery: a pilot study. J Crit Care 38:68\u201372 \n                    https:\/\/doi.org\/10.1016\/j.jcrc.2016.10.017","DOI":"10.1016\/j.jcrc.2016.10.017"},{"key":"255_CR17","doi-asserted-by":"publisher","unstructured":"Geven C, Kox M, Pickkers P (2018) Adrenomedullin and adrenomedullin-targeted therapy as treatment strategies relevant for sepsis. Front Immunol 9:292 \n                    https:\/\/doi.org\/10.3389\/fimmu.2018.00292","DOI":"10.3389\/fimmu.2018.00292"},{"key":"255_CR18","doi-asserted-by":"publisher","unstructured":"Geven C, Peters E, Schroedter M et al (2018) Effects of the humanized anti-adrenomedullin antibody Adrecizumab (HAM8101) on vascular barrier function and survival in rodent models of systemic inflammation and sepsis. Shock 50(6):648-654 \n                    https:\/\/doi.org\/10.1097\/SHK.0000000000001102","DOI":"10.1097\/SHK.0000000000001102"},{"key":"255_CR19","doi-asserted-by":"publisher","unstructured":"Struck J, Hein F, Karasch S, Bergmann A (2013) Epitope specificity of anti-adrenomedullin antibodies determines efficacy of mortality reduction in a cecal ligation and puncture mouse model. Intensive Care Med Exp 1(1):22 \n                    https:\/\/doi.org\/10.1186\/2197-425X-1-3\n                    \n                  . Epub 2013 Oct 29.","DOI":"10.1186\/2197-425X-1-3"},{"key":"255_CR20","doi-asserted-by":"publisher","unstructured":"Wagner K, Wachter U, Vogt JA et al (2013) Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock. Intensive Care Med Exp 1:21 \n                    https:\/\/doi.org\/10.1186\/2197-425X-1-2","DOI":"10.1186\/2197-425X-1-2"},{"key":"255_CR21","doi-asserted-by":"publisher","unstructured":"Lemarie J, Blet A, Bouazza Y et al (2014) Dexamethasone and recombinant human activated protein C improve myocardial function and efficiency during experimental septic shock. Shock Augusta Ga 41:522\u2013527 \n                    https:\/\/doi.org\/10.1097\/SHK.0000000000000148","DOI":"10.1097\/SHK.0000000000000148"},{"key":"255_CR22","doi-asserted-by":"publisher","unstructured":"Pacher P, Nagayama T, Mukhopadhyay P et al (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3:1422\u20131434 \n                    https:\/\/doi.org\/10.1038\/nprot.2008.138","DOI":"10.1038\/nprot.2008.138"},{"key":"255_CR23","doi-asserted-by":"publisher","unstructured":"Milliez P, Messaoudi S, Nehme J et al (2009) Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure. Am J Physiol Heart Circ Physiol 296:H435\u2013H441 \n                    https:\/\/doi.org\/10.1152\/ajpheart.00591.2008","DOI":"10.1152\/ajpheart.00591.2008"},{"key":"255_CR24","doi-asserted-by":"publisher","unstructured":"Azibani F, Benard L, Schlossarek S et al (2012) Aldosterone inhibits antifibrotic factors in mouse hypertensive heart. Hypertension 59:1179\u20131187 \n                    https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.190512","DOI":"10.1161\/HYPERTENSIONAHA.111.190512"},{"key":"255_CR25","doi-asserted-by":"publisher","unstructured":"Bonnin P, Vilar J, Levy BI (2016) Effect of normovolemic hematocrit changes on blood pressure and flow. Life Sci 157:62\u201366 \n                    https:\/\/doi.org\/10.1016\/j.lfs.2016.01.050","DOI":"10.1016\/j.lfs.2016.01.050"},{"key":"255_CR26","doi-asserted-by":"publisher","unstructured":"Fazal L, Azibani F, Bihry N et al (2014) Akt-mediated cardioprotective effects of aldosterone in type 2 diabetic mice. FASEB J Off Publ Fed Am Soc Exp Biol 28:2430\u20132440 \n                    https:\/\/doi.org\/10.1096\/fj.13-239822","DOI":"10.1096\/fj.13-239822"},{"key":"255_CR27","doi-asserted-by":"publisher","unstructured":"Levy B, Fritz C, Tahon E et al (2018) Vasoplegia treatments: the past, the present, and the future. Crit Care Lond Engl 22:52 \n                    https:\/\/doi.org\/10.1186\/s13054-018-1967-3","DOI":"10.1186\/s13054-018-1967-3"},{"key":"255_CR28","doi-asserted-by":"publisher","unstructured":"Ono Y, Okano I, Kojima M et al (2000) Decreased gene expression of adrenomedullin receptor in mouse lungs during sepsis. Biochem Biophys Res Commun 271:197\u2013202 \n                    https:\/\/doi.org\/10.1006\/bbrc.2000.2606","DOI":"10.1006\/bbrc.2000.2606"},{"key":"255_CR29","doi-asserted-by":"publisher","unstructured":"Shoji H, Minamino N, Kangawa K, Matsuo H (1995) Endotoxin markedly elevates plasma concentration and gene transcription of adrenomedullin in rat. Biochem Biophys Res Commun 215:531\u2013537 \n                    https:\/\/doi.org\/10.1006\/bbrc.1995.2497","DOI":"10.1006\/bbrc.1995.2497"},{"key":"255_CR30","doi-asserted-by":"publisher","unstructured":"Galley HF (2011) Oxidative stress and mitochondrial dysfunction in sepsis. Br J Anaesth 107:57\u201364 \n                    https:\/\/doi.org\/10.1093\/bja\/aer093","DOI":"10.1093\/bja\/aer093"},{"key":"255_CR31","doi-asserted-by":"publisher","unstructured":"Andrades M\u00c9, Morina A, Spasi\u0107 S, Spasojevi\u0107 I (2011) Bench-to-bedside review: sepsis - from the redox point of view. Crit Care Lond Engl 15:230 \n                    https:\/\/doi.org\/10.1186\/cc10334","DOI":"10.1186\/cc10334"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-019-0255-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40635-019-0255-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-019-0255-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:06:21Z","timestamp":1589411181000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-019-0255-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1186\/s40635-019-0255-0","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"26 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were conducted in accordance with the National and European Institutes of Health guidelines for the use of laboratory animals and were approved by the local animal research ethics committee (Lariboisi\u00e8re-Villemin, Paris, France) (77-2014 -ceea9).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A. Blet, B. Deniau, JL Samuel, and A. Mebazaa received travel reimbursements from Adrenomed AG. UMR-S 942 Inserm received a research grant from Adrenomed AG. C. Geven received travel reimbursements from Adrenomed AG. P. Pickkers received travel reimbursements and consultancy fees from Adrenomed AG. A. Caillard, and M. Sadoune declare no competing interests. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"25"}}